Media coverage about Acadia Healthcare (NASDAQ:ACHC) has been trending somewhat positive this week, Accern reports. The research group identifies negative and positive news coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Acadia Healthcare earned a media sentiment score of 0.07 on Accern’s scale. Accern also gave headlines about the company an impact score of 46.9076039498059 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.
Here are some of the media stories that may have impacted Accern Sentiment Analysis’s rankings:
- Why to Keeping Eye on: Infinera Corporation, (NASDAQ: INFN), Acadia Healthcare Company, Inc., (NASDAQ: ACHC … – Stocks In The News (press release) (tradingnewsnow.com)
- What Technical Analysis say About Acadia Healthcare Company, Inc. (NASDAQ:ACHC)? – The Oracle Examiner (oracleexaminer.com)
- Average True Range (ATR) under Consideration – Acadia Healthcare Company, Inc., (NASDAQ: ACHC) – Stock Watch (stocksnewstimes.com)
- $713.96 Million in Sales Expected for Acadia Healthcare Company, Inc. (ACHC) This Quarter (americanbankingnews.com)
- Acadia Healthcare Company, Inc. (ACHC) Short Interest Down 24.0% in October (americanbankingnews.com)
Shares of Acadia Healthcare (NASDAQ:ACHC) traded down $0.63 during trading hours on Wednesday, reaching $27.79. The company’s stock had a trading volume of 1,509,400 shares, compared to its average volume of 1,343,678. The stock has a market capitalization of $2,370.00, a PE ratio of 12.41, a price-to-earnings-growth ratio of 1.05 and a beta of 0.89. The company has a debt-to-equity ratio of 1.30, a current ratio of 1.36 and a quick ratio of 1.36. Acadia Healthcare has a fifty-two week low of $27.44 and a fifty-two week high of $54.34.
A number of equities analysts recently commented on ACHC shares. William Blair began coverage on Acadia Healthcare in a report on Tuesday, July 18th. They set an “outperform” rating for the company. Mizuho increased their target price on Acadia Healthcare from $57.00 to $60.00 and gave the stock a “buy” rating in a research note on Friday, July 28th. UBS AG reissued a “positive” rating and issued a $60.00 target price (up from $54.00) on shares of Acadia Healthcare in a research note on Monday, July 31st. Craig Hallum reissued a “buy” rating and issued a $65.00 target price (up from $52.00) on shares of Acadia Healthcare in a research note on Monday, July 31st. Finally, Deutsche Bank AG increased their target price on Acadia Healthcare from $58.00 to $60.00 and gave the stock a “buy” rating in a research note on Monday, July 31st. Two equities research analysts have rated the stock with a sell rating, six have issued a hold rating and nine have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus price target of $45.15.
TRADEMARK VIOLATION WARNING: This article was first reported by Markets Daily and is the sole property of of Markets Daily. If you are reading this article on another publication, it was illegally copied and reposted in violation of international copyright and trademark legislation. The original version of this article can be read at https://www.themarketsdaily.com/2017/11/15/acadia-healthcare-achc-earns-news-impact-rating-of-0-07.html.
In other news, President Brent Turner sold 206,252 shares of the firm’s stock in a transaction dated Tuesday, August 22nd. The stock was sold at an average price of $50.69, for a total value of $10,454,913.88. Following the transaction, the president now owns 81,106 shares of the company’s stock, valued at $4,111,263.14. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Christopher L. Howard sold 53,713 shares of the firm’s stock in a transaction dated Tuesday, August 22nd. The stock was sold at an average price of $50.69, for a total value of $2,722,711.97. Following the completion of the transaction, the executive vice president now directly owns 147,286 shares in the company, valued at approximately $7,465,927.34. The disclosure for this sale can be found here. Insiders sold 1,824,040 shares of company stock worth $92,460,588 in the last ninety days. Corporate insiders own 11.10% of the company’s stock.
About Acadia Healthcare
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.
Receive News & Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related companies with MarketBeat.com's FREE daily email newsletter.